舒利迭对COPD合并肺大泡的临床观察
【摘要】 目的 观察舒利迭对COPD合并肺大泡的临床疗效。 方法 将120例COPD患者随机分为2组，对照组采用常规治疗，治疗组除常规治疗外，吸入舒利迭治疗12个月，观察2组新发肺大泡病例数及原有肺大泡的变化情况。 结果 治疗组无新发肺大泡病例，原有肺大泡者无变化，较对照组相比均呈差异有统计学意义(P均<0.05)。结论 吸入舒利迭治疗COPD可减少弥漫性肺大泡的发生，延缓肺大泡的进展。【关键词】 舒利迭；肺大泡；慢性阻塞性肺疾病
The clinical observation which COPD with bulla on Salmeterol/fluticasone propionate
GAO Fu-sheng.
The First People’s Hospital of XingYang City,XingYang 450100,HeNan,China
【Abstract】 Objective To approach the therapeutic effect of Salmeterol/fluticasone propionate on COPD with bulla. Methods Divides into 2 groups stochastically 120 example COPD patients, the control group uses the conventional treatment, the treatment group besides the conventional treatment, the inspiration Salmeterol/fluticasone propionate treats 12 months, observe the number of the increasing bullas and the original bulla.Results The treatment group sends the bulla cases of illness greatly not newly, original bulla does not have the change greatly, compares to the control group there were the significance difference.(P<0.05).Conclusion The inspiration Salmeterol/fluticasone propionate treats COPD to be possible to reduce the occurrence which the proliferating bulla, delays progress which the bulla. ......
您现在查看是摘要页，全文长 5796 字符。